The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review
Open accessThe DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Abstract
Background: In order to address the opioid crisis in North America, many regions have adopted preventative strategies, such as prescription drug monitoring programs (PDMPs). PDMPs aim to increase patient safety by certifying that opioids are prescribed in appropriate quantities. We aimed to synthesize the literature on changes in opioid-related harms and consequences, an important measure of PDMP effectiveness. Methods: We completed a systematic review. We conducted a narrative synthesis of opioid-related harms and consequences from PDMP implementation. Outcomes were grouped into categories by theme: opioid dependence, opioid-related care outcomes, opioid-related adverse events, and opioid-related legal and crime outcomes. Results: We included a total of 22 studies (49 PDMPs) in our review. Two studies reported on illicit and problematic use but found no significant associations with PDMP status. Eight studies examined the association between PDMP status and opioid-related care outcomes, of which two found that treatment admissions for prescriptions opioids were lower in states with PDMP programs (p < 0.05). Of the thirteen studies that reported on opioid-related adverse events, two found significant (p < 0.001 and p < 0.05) but conflicting results with one finding a decrease in opioid-related overdose deaths after PDMP implementation and the other an increase. Lastly, two studies found no statistically significant association between PDMP status and opioid-related legal and crime outcomes (crime rates, identification of potential dealers, and diversion). Conclusion: Our study found limited evidence to support overall associations between PDMPs and reductions in opioid-related consequences. However, this should not detract from the value of PDMPs’ larger role of improving opioid prescribing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Evidence is mixed regarding the effect of CM on prenatal care participation; studies have found either increased rates of attendance or no significant effect, with two low-quality studies showing a slight increase in attendance.201”
From The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2024) · cites this paper as [201]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Assessing Bias in Studies of Prognostic Factors
Hayden, J. A., van der Windt, D. A., Cartwright, J. L., Côté, P., & Bombardier, C. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-4-201302190-00009 · Cited by 3,287 · cited 1×
“The QUIPS tool assesses risk of bias across six domains: study participation, study attrition, prognostic factor measurement, outcome measurement, study confounding, statistical analysis and reporting [36].”
MethodSelf-citationAssociation Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths
Bohnert, A. S. B. (2011) · JAMA · doi:10.1001/jama.2011.370 · Cited by 1,509
National and state treatment need and capacity for opioid agonist medication-assisted treatment
Jones, C. M., Campopiano, M., Baldwin, G., & McCance-Katz, E. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302664 · Cited by 668
Brat, G. A., Agniel, D., Beam, A., Yorkgitis, B., Bicket, M., Homer, M., Fox, K. P., Knecht, D. B., McMahill-Walraven, C. N., Palmer, N., et al. (2018) · BMJ · doi:10.1136/bmj.j5790 · Cited by 591
Prescription Drug Monitoring Programs and Death Rates from Drug Overdose
Paulozzi, L. J., Kilbourne, E. M., & Desai, H. A. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01062.x · Cited by 372
Iedema, R., Allen, S., Britton, K., Piper, D., Baker, A., Grbich, C., Allan, A., Jones, L., Tuckett, A., Williams, A., et al. (2011) · BMJ · doi:10.1136/bmj.d4423 · Cited by 306
Patrick, S. W., Fry, C. E., Jones, T. F., & Buntin, M. B. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.1496 · Cited by 299
State Legal Restrictions and Prescription-Opioid Use among Disabled Adults
Meara, E., Horwitz, J. R., Powell, W., McClelland, L., Zhou, W., O'Malley, A. J., & Morden, N. E. (2016) · New England Journal of Medicine · doi:10.1056/nejmsa1514387 · Cited by 251
Do Prescription Monitoring Programs Impact State Trends in Opioid Abuse/Misuse?
Reifler, L. M., Droz, D., Bailey, J. E., Schnoll, S. H., Fant, R., Dart, R. C., & Bucher Bartelson, B. (2012) · Pain Medicine · doi:10.1111/j.1526-4637.2012.01327.x · Cited by 243
Research works printed but not linked: 7
- Brandeis University. Technical assistance guide: history of Prescription drug monitoring programs [internet]. 2018. Available from: https://www.pdmpassist.org/pdf/PDMP_admin/TAG_History_PDMPs_final_20180314.pdf
- McLaughlin S Empirical Essays to inform marijuana legalization and Prescription opioid Abuse policy [internet]. 2016. Available from: http://search.proquest.com/docview/1923434357/
- Veritas Health Innovation. Covidence Systematic Review Software. 2017.
- PRISMA. PRISMA: Transparent Reporting of Systematic Reviews and Meta-Analyses [Internet]. 2015 [cited 2019 Jan 29]. Available from: http://prisma-statement.org/prismastatement/Checklist.aspx
- Microsoft. Excel. 2016.
- StataCorp. Stata 15. 2017.
- Asbridge M, Hayden J, Campbell S, Wilson M, Macdougall P. Utilization and effectiveness of Prescription monitoring programs : a systematic review (CIHR Report). Halifax: In Press; 2018.
Cited by
Strang, J., Volkow, N. D., Degenhardt, L., Hickman, M., Johnson, K., Koob, G. F., Marshall, B. D. L., Tyndall, M., & Walsh, S. L. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0137-5 · Cited by 639
The Opioid Epidemic: A Review of the Contributing Factors, Negative Consequences, and Best Practices
Judd, D., King, C. R., & Galke, C. L. (2023) · Cureus · doi:10.7759/cureus.41621 · Cited by 107
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder
(2024) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001299 · Cited by 78
Bardwell, G., Small, W., Lavalley, J., McNeil, R., & Kerr, T. H. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2021.113986 · Cited by 75
Picco, L., Lam, T., Haines, S., & Nielsen, S. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109090 · Cited by 45
Metadata
- Authors
- Rhodes, E., Wilson, M., Robinson, A., Hayden, J. A., & Asbridge, M.
- Affiliations
- Dalhousie University (CA)
- Corresponding author
- Asbridge, Mark
- Venue
- BMC Health Services Research
- Published
- 2019-11-01
- Volume
- 19
- Issue
- 1
- Pages
- 784-784
- ISSN
- 1472-6963 (ISSN-L)
- PMC
- PMC6825333
- OpenAlex
- W2988262664
- Cited by
- 103
- References
- 53
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 10 · 2023: 26 · 2022: 20 · 2021: 26 · 2020: 6
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- BMC Health Services Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- uO Research (University of Ottawa) (submittedVersion, public-domain)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Canadian Institutes of Health Research (397982)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- prescription drug monitoring programs, opioid epidemic, opioid-related harms, opioid prescribing, opioid use disorder, opioid overdose deaths, opioid side effects, illicit opioid use, drug diversion
- MeSH terms
- Prescription Drug Monitoring Programs, Humans, Opioid-Related Disorders, Program Evaluation, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review. https://app.cochat.ai/papers/10.1186/s12913-019-4642-8
- The paper
- Rhodes, E., Wilson, M., Robinson, A., Hayden, J. A., & Asbridge, M. (2019). The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review. BMC Health Services Research. https://doi.org/10.1186/s12913-019-4642-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
